5 Matching Annotations
  1. Oct 2023
  2. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design
    2
    1. scibot 11 Oct 2023
      RRID:AB_10641291

      DOI: 10.1016/j.isci.2023.107952

      Resource: (BioLegend Cat# 350304, RRID:AB_10641291)

      Curator: @scibot

      SciCrunch record: RRID:AB_10641291

      What is this?
      RRID:AB_10641291
    2. scibot 01 Oct 2023
      RRID:AB_10641291

      DOI: 10.1016/j.isci.2023.107952

      Resource: (BioLegend Cat# 350304, RRID:AB_10641291)

      Curator: @scibot

      SciCrunch record: RRID:AB_10641291

      What is this?
      RRID:AB_10641291
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10558812/
  3. Aug 2022
  4. www.sciencedirect.com www.sciencedirect.com
    Off-The-Shelf Third-Party HSC-Engineered iNKT Cells for Ameliorating GvHD While Preserving GvL Effect in the Treatment of Blood Cancers
    1
    1. scibot 17 Aug 2022
      RRID:AB_10641291

      DOI: 10.1016/j.isci.2022.104859

      Resource: (BioLegend Cat# 350304, RRID:AB_10641291)

      Curator: @scibot

      SciCrunch record: RRID:AB_10641291

      What is this?
      RRID:AB_10641291
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2589004222011312
  5. Nov 2021
  6. www.sciencedirect.com www.sciencedirect.com
    Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
    1
    1. scibot 17 Nov 2021
      350304

      DOI: 10.1016/j.xcrm.2021.100449

      Resource: (BioLegend Cat# 350304, RRID:AB_10641291)

      Curator: @Naa003

      SciCrunch record: RRID:AB_10641291

      What is this?
      RRID:AB_10641291 RRIDCUR:Missing
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379121003177
  7. Jan 2020
  8. www.sciencedirect.com www.sciencedirect.com
    Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer
    1
    1. scibot 13 Jan 2020
      RRID:AB_10641291

      DOI: 10.1016/j.stem.2019.08.004

      Resource: (BioLegend Cat# 350304, RRID:AB_10641291)

      Curator: @ethanbadger

      SciCrunch record: RRID:AB_10641291

      What is this?

      RRID:AB_10641291 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S193459091930339X